Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 4 | 2017 | 2019 | ||||||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
0.700 | 1.000 | 3 | 2016 | 2018 | ||||||||
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 2 | 2017 | 2018 | ||||||||||
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
11 | 65638129 | 5 prime UTR variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
11 | 65644564 | intron variant | G/A | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
11 | 65639398 | intron variant | C/T | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.333 | 3 | 2009 | 2014 | |||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.333 | 3 | 2009 | 2014 | |||||||
|
0.882 | 0.120 | 11 | 65649963 | synonymous variant | G/A | snv | 0.31 | 0.30 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2006 | 2013 | ||||||
|
0.882 | 0.120 | 11 | 65649963 | synonymous variant | G/A | snv | 0.31 | 0.30 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2009 | 2014 | ||||||
|
0.882 | 0.120 | 11 | 65649963 | synonymous variant | G/A | snv | 0.31 | 0.30 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2009 | 2014 | ||||||
|
0.790 | 0.160 | 11 | 65637829 | upstream gene variant | G/A | snv | 0.49 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | < 0.001 | 3 | 2009 | 2014 | |||||||
|
0.790 | 0.160 | 11 | 65637829 | upstream gene variant | G/A | snv | 0.49 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | < 0.001 | 3 | 2009 | 2014 | |||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2006 | 2009 | |||||||
|
0.790 | 0.160 | 11 | 65637829 | upstream gene variant | G/A | snv | 0.49 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2013 | |||||||
|
11 | 65644996 | synonymous variant | G/A;C;T | snv | 0.39; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.080 | 11 | 65641466 | missense variant | C/G;T | snv | 0.15 |
|
0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.882 | 0.120 | 11 | 65649963 | synonymous variant | G/A | snv | 0.31 | 0.30 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 |